» Articles » PMID: 17192512

Primary Prevention of Cardiovascular Diseases in People with Diabetes Mellitus: a Scientific Statement from the American Heart Association and the American Diabetes Association

Abstract

The American Heart Association (AHA) and the American Diabetes Association (ADA) have each published guidelines for cardiovascular disease prevention: The ADA has issued separate recommendations for each of the cardiovascular risk factors in patients with diabetes, and the AHA has shaped primary and secondary guidelines that extend to patients with diabetes. This statement will attempt to harmonize the recommendations of both organizations where possible but will recognize areas in which AHA and ADA recommendations differ.

Citing Articles

Frameshift variation in the HMG-CoA reductase gene and unresponsiveness to cholesterol-lowering drugs in type 2 diabetes mellitus patients.

Khaleqsefat E, Rasul K, Kheder R, Baban S, Baban J Sci Rep. 2025; 15(1):288.

PMID: 39747109 PMC: 11695833. DOI: 10.1038/s41598-024-75461-7.


Diabetes Mellitus and Coronary Revascularization: Comparing Outcomes Between Coronary Artery Bypass Grafting and Percutaneous Coronary Intervention.

Saeed Afridi M, Shehzad Roomi F, Kashif Khan H, Kazim A, Afridi R, Usmani S Cureus. 2024; 16(8):e66166.

PMID: 39233965 PMC: 11372725. DOI: 10.7759/cureus.66166.


Comparative Analysis of Biomarkers in Type 2 Diabetes Patients With and Without Comorbidities: Insights Into the Role of Hypertension and Cardiovascular Disease.

Savvopoulos S, Hatzikirou H, Jelinek H Biomark Insights. 2024; 19:11772719231222111.

PMID: 38707193 PMC: 11069335. DOI: 10.1177/11772719231222111.


Insulin resistance/hyperinsulinemia: an important cardiovascular risk factor that has long been underestimated.

Fazio S, Mercurio V, Tibullo L, Fazio V, Affuso F Front Cardiovasc Med. 2024; 11:1380506.

PMID: 38545338 PMC: 10965550. DOI: 10.3389/fcvm.2024.1380506.


Early effective intervention can significantly reduce all-cause mortality in prediabetic patients: a systematic review and meta-analysis based on high-quality clinical studies.

An X, Zhang Y, Sun W, Kang X, Ji H, Sun Y Front Endocrinol (Lausanne). 2024; 15:1294819.

PMID: 38495794 PMC: 10941028. DOI: 10.3389/fendo.2024.1294819.